A cross-sectional study of nearly 3,000 U.S. counties found that higher medical debt in collections was associated with a higher incidence of late-stage cancer diagnoses. The association was strongest for lung cancer: each 10-percentage-point increase in county-level medical debt was linked to 5.15 additional late-stage cases per 100,000 person-years. Significant increases were also seen for colorectal, cervical, melanoma, kidney, bladder, and head and neck cancers.
The analysis, published in JAMA Network Open, linked 2016 medical debt data with age-adjusted cancer incidence from 2017 through 2021. Mean medical debt prevalence was higher in rural counties than urban ones, and far higher in counties in the highest Social Vulnerability Index quartile versus the lowest (27.4% vs 13.9%). The authors suggest that reducing medical debt and strengthening financial protections may help mitigate barriers to cancer prevention and care.
Breast and prostate cancer did not follow the overall pattern. Breast cancer showed no statistically significant association, while prostate cancer had an inverse association—higher medical debt was linked to fewer late-stage diagnoses, which the authors say may reflect lower diagnostic intensity rather than lower disease burden. An accompanying editorial notes that other studies have tied medical debt to reduced screening and more deaths from screening-eligible cancers, framing medical debt as a modifiable risk factor for delayed care and worse outcomes.